Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Potential therapeutics for effort-related motivational dysfunction: assessing novel atypical dopamine transport inhibitors
    Published on 2024-02-29
    2 years ago
  • GABA release from central amygdala neurotensin neurons differentially modulates ethanol consumption in male and female mice
    Published on 2024-02-27
    2 years ago
  • Bridging minds and policies: supporting early career researchers in translating computational psychiatry research
    Published on 2024-02-27
    2 years ago
  • Stimulant medications in children with ADHD normalize the structure of brain regions associated with attention and reward
    Published on 2024-02-25
    2 years ago
  • Ghrelin decreases sensitivity to negative feedback and increases prediction-error related caudate activity in humans, a randomized controlled trial
    Published on 2024-02-25
    2 years ago
  • Dissecting the genetic overlap between severe mental disorders and markers of cellular aging: Identification of pleiotropic genes and druggable targets
    Published on 2024-02-23
    2 years ago
  • Estimating the direct effects of the genetic liabilities to bipolar disorder, schizophrenia, and behavioral traits on suicide attempt using a multivariable Mendelian randomization approach
    Published on 2024-02-22
    2 years ago
« Previous 1 … 96 97 98 99 100 … 143 Next »
Journal of Psychopharmacology
  • Effect of medication on risk of traumatic brain injury in patients with bipolar disorder: A nationwide population-based cohort study
    Published on 2021-05-03
    5 years ago
  • Equasy revisited
    Published on 2021-05-03
    5 years ago
  • The biologically active compound of Withania somnifera (L.) Dunal, docosanyl ferulate, is endowed with potent anxiolytic properties but devoid of typical benzodiazepine-like side effects
    Published on 2021-05-03
    5 years ago
  • Selective attention to emotional stimuli and emotion recognition in patients with major depression: The role of mineralocorticoid and glutamatergic NMDA receptors
    Published on 2021-04-28
    5 years ago
  • Discontinuation and relapse with paliperidone palmitate three-monthly for maintenance of schizophrenia: Two year follow-up of use in clinical practice
    Published on 2021-04-28
    5 years ago
  • Easier patient access to medical cannabis carries risks as well as benefits
    Published on 2021-04-28
    5 years ago
  • Hydrocortisone as an adjunct to brief cognitive-behavioural therapy for specific fear: Endocrine and cognitive biomarkers as predictors of symptom improvement
    Published on 2021-04-28
    5 years ago
« Previous 1 … 96 97 98 99 100 … 150 Next »
European Neuropsychopharmacology
  • The unrealized promise of cerebrovascular magnetic resonance imaging in psychiatric research across the lifespan
    Published on 2021-11-06
    5 years ago
  • Recommendations for pharmacotranscriptomic profiling of drug response in CNS disorders
    Published on 2021-11-04
    5 years ago
  • Corrigendum to “Abstracts of the Virtual World Congress of Psychiatric Genetics (WCPG), October 11-15, 2021 – Oral abstracts. [European Neuropsychopharmacology 51 (2021) e40–e93]”
    Published on 2021-11-02
    5 years ago
  • The impact of the prolonged COVID-19 pandemic on stress resilience and mental health: a critical review across waves
    Published on 2021-10-29
    5 years ago
  • Promoting good mental health in the whole population: The new frontier
    Published on 2021-10-25
    5 years ago
  • Reduced prefrontal cortex response to own vs. unknown emotional infant faces in mothers with bipolar disorder
    Published on 2021-10-24
    5 years ago
  • How to reduce and stop psychiatric medication
    Published on 2021-10-22
    5 years ago
« Previous 1 … 96 97 98 99 100 … 168 Next »

   Pharma Pub